XML 22 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES: (Details 3) (USD $)
 9 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2012
Apr. 30, 2012
Apr. 10, 2012
Jun. 30, 2012
Stock Options
Sep. 30, 2011
Stock Options
Jun. 30, 2012
Stock Options
Consultants
Jun. 30, 2012
Restricted Stock
Jun. 30, 2012
Employee stock options
Jun. 30, 2012
Employee stock options
Executive officers
Jun. 30, 2012
Warrants
Consultants
Jun. 30, 2012
Warrants
Consultants
item
Number of Shares                      
Outstanding at the beginning of the period (in shares)       1,537,500              
Granted (in shares)       275,000   25,000          
Cancelled (in shares)       (350,000)         (212,500)    
Outstanding at the end of the period (in shares)       1,462,500 1,537,500            
Weighted Average Exercise Price                      
Outstanding at the beginning of the period (in dollars per share)       $ 1.19              
Granted (in dollars per share)       $ 1.39   $ 1.88          
Cancelled (in dollars per share)       $ 1.38              
Outstanding at the end of the period (in dollars per share)       $ 1.19 $ 1.19            
Weighted Average Remaining Contractual Term                      
Outstanding at the beginning of the period       8 years 9 months 18 days 9 years 3 months 18 days            
Outstanding at the end of the period       8 years 9 months 18 days 9 years 3 months 18 days            
Aggregate Intrinsic Value                      
Outstanding at the beginning of the period (in dollars)       $ 743,785              
Outstanding at the end of the period (in dollars)       158,375 743,785            
Other disclosures                      
Options outstanding that were vested and exercisable (in shares)       462,500              
Additional options outstanding that are expected to vest (in shares)       1,000,000              
Options expiring (in shares)               137,500      
Options outstanding (in shares)             52,500        
Remaining costs related to non-vested restricted stock awards (in dollars)             150,000        
Warrants granted to purchase common stock (in shares)                   20,000 20,000
Exercise price of warrants (in dollars per share)   $ 1.30 $ 1.30             $ 2.28 $ 2.28
Number of equal annual installments in which warrants vest                     2
Warrant expense recognized (in dollars) 9,000                 3,000 9,000
Warrant expense unrecognized (in dollars)                     $ 15,000